Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
Sign Up to like & getrecommendations! Published in 2018 at "World Journal of Surgery"
DOI: 10.1007/s00268-018-4558-1
Abstract: ObjectiveSurgical resection is the only available treatment for achieving long-term survival in cholangiocarcinoma. The purpose of this study is to elucidate the utility of chemoradiotherapy for initially unresectable locally advanced cholangiocarcinoma.MethodsUnresectable locally advanced cholangiocarcinoma was… read more here.
Keywords: initially unresectable; chemoradiotherapy; cholangiocarcinoma; advanced cholangiocarcinoma ... See more keywords
Phase II study of pembrolizumab plus olaparib in the treatment of patients with advanced cholangiocarcinoma.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.tps4659
Abstract: TPS4659Background: Lack of an effective second-line treatment of patients (pts) with advanced cholangiocarcinoma (CC) necessitates the development of new therapies. Preclinical studies suggest CC s... read more here.
Keywords: treatment patients; pembrolizumab plus; advanced cholangiocarcinoma; study pembrolizumab ... See more keywords
Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Surgery"
DOI: 10.1200/jco.2022.40.4_suppl.387
Abstract: BACKGROUND This study was conducted to evaluate the clinical feasibility of nab-paclitaxel plus gemcitabine-cisplatin triplet chemotherapy in patients with locally advanced cholangiocarcinoma in real-world practice. METHODS We retrospectively reviewed patients with locally advanced cholangiocarcinoma who… read more here.
Keywords: locally advanced; paclitaxel plus; advanced cholangiocarcinoma; plus gemcitabine ... See more keywords
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib
Sign Up to like & getrecommendations! Published in 2021 at "OncoTargets and therapy"
DOI: 10.2147/ott.s272208
Abstract: Abstract Cholangiocarcinoma is one of the most aggressive cancers, with a 5-year survival rate of 11–44% after surgical resection. However, there is no established systemic therapy after failure of the gemcitabine plus cisplatin first-line therapy… read more here.
Keywords: cholangiocarcinoma; therapy advanced; genomic aberrations; advanced cholangiocarcinoma ... See more keywords
Clinical Significance of Venous Thromboembolism in Patients with Advanced Cholangiocarcinoma.
Sign Up to like & getrecommendations! Published in 2023 at "Gut and liver"
DOI: 10.5009/gnl220477
Abstract: Background/Aims Patients with active cancer frequently develop venous thromboembolism (VTE). However, there is little data about VTE in patients with advanced cholangiocarcinoma (CCA). Therefore, we investigated the clinical significance of VTE in patients with advanced… read more here.
Keywords: advanced cholangiocarcinoma; clinical significance; survival; patients advanced ... See more keywords